Improving Health Care Productivity Means ‘Locking Arms With Providers’
Philips is looking beyond COVID-19 and to building more partnership-based relationships in health care delivery
Executive Summary
Royal Philips would not routinely invest 10% of its sales in R&D without working with providers to discover their precise needs, says CEO Frans van Houten.
You may also be interested in...
Philips Extends Leadership In Patient Monitoring By Buying BioTelemetry For $2.8Bn
Philips is already the leader in hospital patient monitoring and adding BioTelemetry will make it also the top provider of ambulatory cardiac diagnostics and monitoring systems.
The Balancing Act For HealthTech Providers In The Post-COVID-19 Era Of Volatility
How quickly health care delivery returns to pre-COVID-19 routines is the million-dollar question. With coronavirus volatility still a worrying reality and the burden of chronic care ever present, medtech companies that partner with provider systems must ensure they are covering all the bases. For Royal Philips’ Roy Jakobs, this means delivering on the promises of connected care.
Olympus Medical Follows The Patient Pathway In New Strategic Plan
Having divested non-medical imaging a year ago, Olympus Corp is putting its foot to the floor in refocusing on its medical portfolio. It has set global ambitions of strengthening its coverage of unmet needs and of playing a major role in reshaping health care delivery.